Berliner Abendpost - Merck charged in France over changes to popular thyroid drug

NYSE - LSE

CMSC	0.18%	21.99	$
GSK	4.4%	53.66	$
RBGPF	3.73%	68.15	$
RELX	1.72%	31.93	$
NGG	3.22%	82.85	$
RYCEF	2.74%	19.68	$
AZN	5.79%	195.15	$
CMSD	-0.14%	22.15	$
RIO	1.13%	94.42	$
BCE	1.87%	21.42	$
BTI	1.96%	61.77	$
BCC	0.59%	75.93	$
JRI	0.46%	13	$
VOD	1.06%	13.15	$
BP	3.34%	37.4	$

Merck charged in France over changes to popular thyroid drug

BOULEVARD 19.10.2022

Merck charged in France over changes to popular thyroid drug / Photo: REMY GABALDA - AFP/File

The French unit of German pharmaceuticals firm Merck said Wednesday that it had been charged with "aggravated deceit" for failing to inform patients of changes to a thyroid drug that could result in serious new side-effects.

Text size:

A court had already ordered the company in 2020 to pay compensation to more than 3,300 plaintiffs in a civil case, and an appeal of that ruling was rejected by France's supreme court earlier this year.

Some 30,000 people in France reported headaches, insomnia, hair loss or dizziness from taking a new version of Levothyrox, a drug used to treat underactive thyroids or following surgery for cancer of the organ, which regulates the body's metabolism.

France is the world's biggest consumer of Levothyrox, with around 2.5 million users according to Merck, and was the first country where the new version of the drug was introduced in 2017.

The patients claim that Merck did not adequately inform them of the changes or the potential for new side effects, and a petition urging a return to the old formula has garnered some 170,000 signatures.

Merck France said its president was questioned by a judge in the southern city of Marseille on Tuesday, after which the deceit charges were filed.

"This charge in no way concerns the quality of the new Levothyrox formula," the company said, adding that it would provide "all necessary information to show there was no criminal fault of any kind".

In the civil case, judges ordered Merck to pay each of the 3,329 parties 1,000 euros ($980 at current exchange rates). The plaintiffs had asked for ten times that amount.

After its introduction in France, the new form of the drug was rolled out in around two dozen other European countries, without any problems, according to Merck.

It has said that any side effects are "normal and comparable to the old" formula.

Z.Franke--BlnAP

Featured

Man dies after setting self ablaze outside UN in New York: police

A man died after setting himself on fire outside the UN's headquarters in New York on Thursday, police said, with activists and reports identifying him as a pro-Tibet campaigner.

Death toll hits 10 in Thai monk procession crash

The number of monks killed has risen to 10 after an 11-year-old boy drove a pickup truck into a Buddhist procession in Thailand, officials said Friday.

Tajik names for Tajik babies: strict rules leave parents stranded

After giving birth, Shakhnoza Nazarova thought registering her daughter's name would be a mere formality. Instead, her chosen name was rejected -- deemed not Tajik enough by authorities of the Central Asian country.

Macabre night in La Guaira, Venezuela's earthquake epicenter

A macabre darkness, the glare of spotlights, the droning of generators and jackhammers, and often the stench of decomposing corpses: eight days after the double earthquake in Venezuela, nighttime in La Guaira, once a festive seaside resort, has transformed into a grim scene of survival and despair.